The below Parliamentary question was asked by Greg Mulholland on 2015-10-14.
To ask the Secretary of State for the Home Department, what the membership of the Community Engagement Forum is.
Mr John Hayes
The Community Engagement Forum met for the first time on 13 October. Attendance at forum meetings will rotate to allow ministers to hear directly from a wide range of individuals and groups taking a leading role in challenging extremism in our communities.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Health, what timetable NHS England has set for developing a commissioning policy for the Everolimus drug.
George Freeman
NHS England is currently developingtwo policies for the provision of Everolimus – one for the Tuberous Sclerosis forComplex Related Renal Angiomyolipoma andone for SubependymalGiant Cell Astrocytoma (SEGA). This was communicated to the National Health Service in a Specialised Services Circular on 2 July 2015.
These two policies will both be considered as in-year items for the specialised services work programme for 2015/16- however, a timetable for publication has not yet been agreed.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Health, when he expects NICE to publish its final guidance on the Vimizim treatment.
George Freeman
The National Institute for Health and Care Excellence currently expects to publish its final guidance on elosulfase alfa (Vimizim) for mucopolysaccharidosis (type IVA) or Morquio Syndrome in December 2015.
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Health, what recent representations (a) NHS England and (b) NICE have received from (i) drug companies and (ii) patient groups on the treatment of uveitis.
Alistair Burt
NHS England has received 12 letters from hon. Members and has met with key stakeholders, including patient organisations and charities such as the Royal National Institute of Blind People and Olivia’s Vision. This followed their decision in July not to fund Infliximab (Remicade) and Adalimumab (Humira), Anti-TNF drugs, as a treatment for adults and children with severe refractory uveitis.
NHS England has also been in discussion with Abbvie, a Pharmaceutical Research and Development Company which is due to report on their trial of Adalimumab in adults in early 2016.
The National Institute for Health and Care Excellence (NICE) is developing technology appraisal guidance on the use of the drugs dexamethasone and sorolimus for the treatment of uveitis. NICE develops its technology appraisal guidance in consultation with a broad range of stakeholders and the representations it receives in the development of its guidance will be available on the NICE website at:
http://www.nice.org.uk/guidance/indevelopment/gid-ta10007
NICE has not received any representations about uveitis not related to this ongoing technology appraisal.
“
The below Parliamentary question was asked by Greg Mulholland on 2015-10-13.
To ask the Secretary of State for Health, what estimate he has made of the number of people with uveitis; and what treatment is available for that condition at what cost.
Alistair Burt
Patients with uveitis are usually diagnosed and treated in primary care and no data is collected which would identify how many patients with this condition are seen and treated. Information provided by the Health and Social Care Information Centre for secondary care, shows that for 2013/14 there were 7,226 admissions to hospital where a diagnosis of uveitis has been recorded.
The main treatment for uveitis is with steroids, which can reduce the inflammation inside the eye. In some cases additional treatment might be needed, such as immunosuppressants.
The costs associated with these drugs are around £150 per adult patient per year and £35 per paediatric patient per year.
The below Parliamentary question was asked by Greg Mulholland on 2015-02-10.
To ask the Attorney General, what steps he is taking to implement the recommendations of the report from HM Crown Prosecution Service Inspectorate and HM Inspectorate of Constabulary entitled Joint Inspection of the Investigation and Prosecution of Fatal Road Traffic Incidents, published in February 2015.
Jeremy Wright
It is clear from the joint HMIC and HMCPSI report that there must be improvements in the way offences arising out of fatal road traffic incidents are investigated and prosecuted. It is therefore vital that police forces give due regard to the recommendations made in the report. However, it is rightly a matter for chief constables and Police and Crime Commissioners (PCCs) to ascertain how best to respond to the recommendations locally. Under Section 55 (5) of the Police Act 1996, all PCCs have a statutory requirement to publish their response to joint inspection reports that relate to their force.
The CPS must provide the best possible service to the bereaved families in these cases. Whilst many of the recommended improvements have been achieved through more general development of CPS casework and guidance, there is clearly more which needs to be done. In order to make the improvements necessary to the prosecution of offences arising out of fatal road traffic accidents, the CPS is taking or has committed to take the following steps:
The below Parliamentary question was asked by Greg Mulholland on 2015-02-20.
To ask the Secretary of State for Health, what steps he is taking to ensure that patients deemed to have critical need are not affected by the time taken by NHS England to draft a new commissioning policy for ultra-rare treatments.
Jane Ellison
NHS England has responsibility for the commissioning of specialised services and is currently consulting on changes to the principles and processes by which it makes decisions on prioritising investment in specialised services.
NHS England has provided assurance that any prioritisation which is urgent on clinical grounds will continue to be dealt with quickly through their existing procedures. The route for individual funding requests remains in place.
The consultation can be found at:
www.engage.england.nhs.uk/consultation/investing-in-specialised-commissioning
“
The below Parliamentary question was asked by Greg Mulholland on 2015-09-16.
To ask the Secretary of State for the Home Department, if she will estimate the number of asylum seeker applicants in the UK who were living in poverty in each of the last five years.
James Brokenshire
If asylum seekers are destitute they are provided with support by the UK taxpayer. The support usually consists of accommodation and a cash allowance to cover essential living needs.
The cash allowance is also provided if the asylum seeker is living with friends or relatives but needs assistance to meet their essential living needs.
The below Parliamentary question was asked by Greg Mulholland on 2015-09-16.
To ask the Secretary of State for the Home Department, what proportion of asylum seeker applications made by Syrian nationals in each of the last five years received a decision in (a) three, (b) six and (c) 12 months.
Mr John Hayes
The tables below shows the proportion of asylum claims from Syrian nationals which received an initial decision within 3 months, 6 months and 12 months from 2010 to 2013. This data is based on main asylum claimants who made a claim for asylum from 1 October 2010 to 31 December 2014. We aim to decide all straightforward asylum claims within six months. We recognise that asylum cases are often complex and require our full and thorough consideration, meaning that some decisions will take longer than six months. Those cases that do take longer than six months are actively managed to ensure they are concluded as promptly as possible.
|
Year Application made |
Time from Application to Date of Decision |
||||
|
Decision made within 3 Months |
Within 6 Months |
Within 1 Year |
More than 1 Year |
No Decision made |
|
|
2010 |
117 |
5 |
5 |
1 |
0 |
|
Grand Total |
117 |
5 |
5 |
1 |
0 |
|
2011 |
273 |
36 |
20 |
23 |
0 |
|
Grand Total |
273 |
36 |
20 |
23 |
0 |
|
2012 |
819 |
77 |
64 |
21 |
1 |
|
Grand Total |
819 |
77 |
64 |
21 |
1 |
|
2013 |
1130 |
157 |
203 |
97 |
29 |
|
Grand Total |
1130 |
157 |
203 |
97 |
29 |
|
2014 |
603 |
1036 |
177 |
34 |
143 |
|
Grand Total |
603 |
1036 |
177 |
34 |
143 |
“
The below Parliamentary question was asked by Greg Mulholland on 2015-09-16.
To ask the Secretary of State for the Home Department, how many asylum seeker applications were received from Syrian nationals in each of the last five years; and how many such applicants were (a) refused, (b) granted refugee status, (c) granted humanitarian protection and (d) granted discretionary leave to remain.
James Brokenshire
The Home Office publishes an analysis of applications for whole-year cohorts of asylum seekers to establish the overall success rates following appeal; this is available in Table as_06 (Asylum data table Volume 2) of the quarterly Immigration Statistics release. For the latest years, some cases will still be outstanding. This cohort analysis is therefore not able to provide a complete picture for the latest applications but for most years will provide the most complete description of the outcome for asylum seekers. The analysis of the outcomes of asylum applications are the recorded outcomes of the group (or cohort) of applicants in any one year, at a particular time. This dataset is updated, in full, annually and is currently available up to 2014.
Insert Table
A copy of the latest release, Immigration Statistics April – June 2015, is available from https://www.gov.uk/government/organisations/home-office/series/immigration-statistics-quarterly-release.